Am J Transplant, Volume 21, Suppl 3 Archives - Page 134 of 139 - ATC Abstracts

2021 American Transplant Congress
Graft Outcomes of Antibody Mediated Rejection without Donor Specific Anti – HLA Antibodies After Kidney Transplantation
H. Ko, S. Min, A. Han, S. Ahn, C. T. Chung, H. Kim, K. Choi, S. Min, H. Kang, J. Ha
Seoul National University Hospital, Seoul, Korea, Republic of
*Purpose: The aim of this study was to investigate graft outcomes based on the presence of donor-specific anti-HLA antibodies (DSA) and the time of diagnosis…
2021 American Transplant Congress
Clazakizumab for the Treatment of Chronic Active Antibody-Mediated Rejection in Kidney Transplant Recipients: Phase 3 IMAGINE Study Design
P. Nickerson¹, G. Böhmig², S. Chadban³, D. Kumar⁴, R. B. Mannon⁵, T. van Gelder⁶, S. Adler⁷, E. Chong⁷, A. Djamali⁸
¹University of Manitoba, Winnipeg, MB, Canada, ²Medical University of Vienna, Vienna, Austria, ³University of Sydney, Sydney, Australia, ⁴University of Toronto, Toronto, ON, Canada, ⁵University of Nebraska Medical Center, Omaha, NE, ⁶Leiden University Medical Center, Leiden, Netherlands, ⁷CSL Behring, King of Prussia, PA, ⁸University of Wisconsin, Madison, WI
*Purpose: Chronic active antibody-mediated rejection (CAMR) is a major cause of allograft loss with no approved drugs for its treatment. Currently, off-label regimens recommended by…
2021 American Transplant Congress
Recurrence and Outcome of Anti-GBM Glomerulonephritis After Kidney Transplantation: A Belgian Multicenter Study
S. Coche
Nephrology, Cliniques Universitaires Saint-Luc, Brussels, Belgium
*Purpose: Recurrence of anti-glomerular basement membrane (anti-GBM) glomerulonephritis (GN) in the kidney graft is a rare event, described in limited case reports and registry analysis.…
2021 American Transplant Congress
Serum Phosphatidylethanol is Superior to Urine Ethyl Glucuronide for Diagnosis of Alcohol Relapse in Liver Transplant Recipients
N. Lim¹, T. Leventhal¹, M. Thomson¹, M. Hassan¹, J. Thompson¹, S. Chinnakotla², V. Kirchner², T. Pruett², R. Kandaswamy², V. Humphreville², A. Adams², J. Lake¹
¹Divison of Gastroenterology, Hepatology and Nutrition, University of Minnesota, Minneapolis, MN, ²Divison of Transplantation, University of Minnesota, Minneapolis, MN
*Purpose: Liver transplantation (LT) for alcohol-related liver disease (ALD) is increasing. The primary issue in these patients is often recidivism, therefore screening for ETOH use…
2021 American Transplant Congress
Longitudinal Quality of Life Assessment in Liver Transplant – Feasibility Study and Early Results
O. M. Siddiqui, P. Polineni, A. J. Thuluvath, C. Loftus
Northwestern University, Chicago, IL
*Purpose: In addition to survival, quality of life (QoL) is critical to optimizing care in liver transplantation (LT). Although QoL is associated with clinical outcomes…
2021 American Transplant Congress
Serum Phosphatidylethanol is Superior to Urine Ethyl Glucuronide for Detection of Alcohol Use in Pre-transplant Patients
N. Lim¹, T. Leventhal¹, M. Thomson¹, M. Hassan¹, J. Thompson¹, S. Chinnakotla², V. Kirchner², T. Pruett², R. Kandaswamy², V. Humphreville², A. Adams², J. Lake¹
¹Division of Gastroenterology, Hepatology and Nutrition, University of Minnesota, Minneapolis, MN, ²Division of Transplantation, University of Minnesota, Minneapolis, MN
*Purpose: More patients are presenting for liver transplant (LT) evaluation for alcohol-related liver disease (ALD). Detection of ETOH use has significant implications for patients undergoing…
2021 American Transplant Congress
Albumin Level Prior to Liver-Directed Therapy is a Risk Factor of Waitlist Tumor Progression Independent of HCC Burden
P. Thevenot, K. Nunez, T. Sandow, M. Hibino, P. Wright, J. Patel, D. Fort, A. Cohen
Ochsner Health, New Orleans, LA
*Purpose: Milan Criteria, α-fetoprotein (AFP), and MELD score at diagnosis influence prognosis in bridge to transplant (BTT) hepatocellular carcinoma (HCC). With HCC surveillance many patients…
2021 American Transplant Congress
A Comparison Between Combined Liver Kidney Transplants to Liver Transplants Alone: A Systematic Review and Meta-analysis
S. Bouari¹, E. A. Rijkse¹, H. J. Metselaar², M. W. van den Hoogen³, J. N. Ijzermans¹, J. de Jonge¹, W. G. Polak¹, R. C. Minnee¹
¹Surgery, Division of HPB & Transplant Surgery, Erasmus MC, Rotterdam, Netherlands, ²Gastroenterology and Hepatology, Erasmus MC, Rotterdam, Netherlands, ³Internal Medicine, Section of Nephrology and Transplantation, Erasmus MC, Rotterdam, Netherlands
*Purpose: Since the introduction of the Model for End-stage Liver disease (MELD) criteria in 2002, more combined liver kidney transplants are performed. Until 2017, no…
2021 American Transplant Congress
When One Size Does Not Fit All: Geographically Heterogeneous Liver Distribution
M. A. Mankowski¹, S. Gentry², D. Segev³, N. Trichakis⁴
¹KAUST, Thuwal, Saudi Arabia, ²US Naval Academy, Annapolis, MD, ³JHU, Baltimore, MD, ⁴MIT, Boston, MA
*Purpose: The new liver allocation system prioritizes distribution within acuity circles, instead of within DSAs. Acuity circles have the same radius around all donor hospitals…
2021 American Transplant Congress
Adults Undergoing First Time Liver Transplantation with Biliary Atresia: An Analysis of the United Network for Organ Sharing Database
E. Hsu¹, J. Perkins², S. P. Horslen¹, A. A. Dick¹, N. M. Blondet¹, J. D. Reyes²
¹Seattle Children's Hospital, Seattle, WA, ²Surgery, University of Washington School of Medicine, Seattle, WA
*Purpose: Although biliary atresia (BA) is the most common indication for liver transplantation in children, there is no published data on outcomes for individuals who…